Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Lipotoxicity as a therapeutic target in obesity and diabetic cardiomyopathyJournal of pharmacy & pharmaceutical sciences, 2024-04, Vol.27 [Peer Reviewed Journal]EISSN: 1482-1826 ;DOI: 10.3389/jpps.2024.12568Full text available |
|
2 |
Material Type: Article
|
Effect of extruded djulis (Chenopodium formosanum) snacks on the ameliorative potential against diabetic cardiomyopathyJournal of functional foods, 2024-05, Vol.116, p.106154 [Peer Reviewed Journal]ISSN: 1756-4646 ;EISSN: 2214-9414Full text available |
|
3 |
Material Type: Article
|
Exosomal miR-9-5p derived from iPSC-MSCs ameliorates doxorubicin-induced cardiomyopathy by inhibiting cardiomyocyte senescenceJournal of nanobiotechnology, 2024-04, Vol.22 (1), p.195-19 [Peer Reviewed Journal]2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;The Author(s) 2024 ;ISSN: 1477-3155 ;EISSN: 1477-3155 ;DOI: 10.1186/s12951-024-02421-8 ;PMID: 38643173Full text available |
|
4 |
Material Type: Article
|
Signal-averaged electrocardiography as a noninvasive tool for evaluating the ventricular substrate in patients with nonischemic cardiomyopathy: reassessment of an old toolFrontiers in cardiovascular medicine, 2024-04, Vol.11 [Peer Reviewed Journal]EISSN: 2297-055X ;DOI: 10.3389/fcvm.2024.1306055Full text available |
|
5 |
Material Type: Article
|
Comparative analysis of health-related fitness in patients with acute versus chronic Chagas diseaseBiomédica, 2024-03, Vol.44 (1), p.67-79 [Peer Reviewed Journal]ISSN: 0120-4157 ;EISSN: 2590-7379 ;DOI: 10.7705/biomedica.6892Full text available |
|
6 |
Material Type: Article
|
Coronary microvascular dysfunction in childhood: An emerging pathological entity and its clinical implicationsAmerican heart journal plus, 2024-06, Vol.42, p.100392 [Peer Reviewed Journal]EISSN: 2666-6022Full text available |
|
7 |
Material Type: Article
|
Endoplasmic reticulum stress-related gene expression causes the progression of dilated cardiomyopathy by inducing apoptosisFrontiers in genetics, 2024-04, Vol.15 [Peer Reviewed Journal]EISSN: 1664-8021 ;DOI: 10.3389/fgene.2024.1366087Full text available |
|
8 |
Material Type: Article
|
A curious Takotsubo cardiomyopathy after COVID-19IDCases, 2024-01, Vol.36, p.e01958 [Peer Reviewed Journal]EISSN: 2214-2509Full text available |
|
9 |
Material Type: Article
|
Analysis of long-term prognosis and risk factors in patients with dilated cardiomyopathyZhōnghuá xīnxuèguănbìng zázhì, 2024-04, Vol.52 (4), p.384ISSN: 0253-3758 ;PMID: 38644253Digital Resources/Online E-Resources |
|
10 |
Material Type: Newsletter Article
|
Applied Therapeutics (APLT: $4.48) tumbles 5.5%, 2 days' volume in a day; -26c [5.5%] Vol Index 2.0 [1 is avg]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd Apr 20, 2024Digital Resources/Online E-Resources |
|
11 |
Material Type: Newsletter Article
|
Tenaya Therapeutics (TNYA: $4.32) increases; +3c [0.7%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd Apr 20, 2024Digital Resources/Online E-Resources |
|
12 |
Material Type: Newsletter Article
|
UPDATE: Cytokinetics (CYTK: $66.81) keeps sliding, down 3.2% in 3 days; -$2.19 [3.2%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd Apr 20, 2024Digital Resources/Online E-Resources |
|
13 |
Material Type: Newsletter Article
|
Intellia Therapeutics (NTLA: $21.57) rises 1.2% on increasing volatility; +25c [1.2%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd Apr 20, 2024Digital Resources/Online E-Resources |
|
14 |
Material Type: Newsletter Article
|
Solid Biosciences (SLDB: $8.70) falls in 4 out of last 5 days, 5-day fall of 16%; -56c [6.0%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd Apr 20, 2024Digital Resources/Online E-Resources |
|
15 |
Material Type: Newsletter Article
|
Lexeo Therapeutics (LXEO: $12.05) decreases; -2c [0.2%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd Apr 20, 2024Digital Resources/Online E-Resources |
|
16 |
Material Type: magazinearticle
|
Transthyretin amyloid cardiomyopathy: acoramidisManufacturing chemist (London : 1981), 2024-04, Vol.95 (4), p.30COPYRIGHT 2024 HPCi Media Ltd. ;ISSN: 0262-4230Digital Resources/Online E-Resources |
|
17 |
Material Type: Newspaper Article
|
Hypertrophic Cardiomyopathy Pipeline Review, 2024 Updates | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | Tenaya Therapeutics, ShandongM2 Presswire, 2024-04-18COPYRIGHT 2024 Normans Media Ltd.Digital Resources/Online E-Resources |
|
18 |
Material Type: Article
|
Research progress on mitochondrial metabolic microenvironment and cardiac fibrosisZhōnghuá xīnxuèguănbìng zázhì, 2024-04, Vol.52 (4), p.425ISSN: 0253-3758 ;PMID: 38644259Digital Resources/Online E-Resources |
|
19 |
Material Type: Article
|
Editorial: Multi-omics in cardiomyopathies causing heart failure: from mechanism to treatmentFrontiers in cardiovascular medicine, 2024-04, Vol.11 [Peer Reviewed Journal]EISSN: 2297-055X ;DOI: 10.3389/fcvm.2024.1405813Full text available |
|
20 |
Material Type: Article
|
Diastolic dysfunction in aortic stenosis: Old pathophysiologic observations made a new toolEchocardiography (Mount Kisco, N.Y.), 2024-04, Vol.41 (4), p.e15816 [Peer Reviewed Journal]EISSN: 1540-8175 ;PMID: 38643458Digital Resources/Online E-Resources |